2024年8月27日 · Clinical manifestations of acute GVHD include a classic maculopapular rash; persistent nausea and/or emesis; abdominal cramps with diarrhea; and a rising serum bilirubin …

2023年2月21日 · Acute graft versus host disease (aGvHD): aGvHD occurs shortly after your transplant, usually within the first 100 days. But symptoms of aGvHD may also start later. …

2024年6月7日 · GVHD can manifest as acute or chronic forms, each with distinct clinical presentations and management strategies. This activity provides an in-depth exploration of …

2021年12月10日 · We review contemporary approaches to the risk stratification and initial treatment of aGVHD, including ongoing clinical trials. We summarize the findings that led to …

2023年6月8日 · Acute graft-versus-host disease (GVHD) is a common immune complication that can occur after allogeneic haematopoietic cell transplantation (alloHCT). Acute GVHD is a …

Acute graft-versus-host disease (GVHD) occurs after allogeneic hematopoietic stem cell transplant and is a reaction of donor immune cells against host tissues. Activated donor T cells …

2024年4月11日 · Acute GvHD occurs until day 100 as classical acute GvHD and beyond day 100 as delayed acute GvHD. As treatment options are limited beyond the use of corticosteroids, …

2025年3月27日 · GVHD is the leading cause of non-relapse mortality in patients with cancer who have received transplant and limits who can receive a transplant. It can lead to severe …

2017年11月30日 · Signs of typical acute GVHD include a maculopapular rash; hyperbilirubinemia with jaundice due to damage to the small bile ducts, leading to cholestasis; nausea, vomiting, …

Acute GVHD typically occurs during the first months after the stem cell transplant. It affects the skin, digestive tract or liver and can manifest as a rash, elevated liver enzymes, or …